Larvol Delta - CDRLife-is-also-presenting-a-poster-on-CDR609-the-companys-newest-T-cell-engager-clinical-candidate-that-targets-LGR5-a-highly-cancerspecic-cell-surface-antigen-widely-expressed-on-common-solid-tumors

CDR609 - CDR-Life

https://www.businesswire.com/news/home/20251023009760/en/CDR-Life-Presents-Early-Clinical-Data-Demonstrating-Pharmacodynamic-Activity-of-CDR404-a-Novel-Antibody-Derived-T-Cell-Engager-Targeting-MAGE-A4-Solid-Tumors

Oct 23, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next